Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis

Saved in:
Bibliographic Details
Main Authors: Eric M. Tong, MD, Hui Zhou, PhD, Katherine Pak, MS, Cheng-Wei Huang, MD, Benjamin I. Broder, MD, PhD, John J. Sim, MD
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059525000093
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042644406730752
author Eric M. Tong, MD
Hui Zhou, PhD
Katherine Pak, MS
Cheng-Wei Huang, MD
Benjamin I. Broder, MD, PhD
John J. Sim, MD
author_facet Eric M. Tong, MD
Hui Zhou, PhD
Katherine Pak, MS
Cheng-Wei Huang, MD
Benjamin I. Broder, MD, PhD
John J. Sim, MD
author_sort Eric M. Tong, MD
collection DOAJ
format Article
id doaj-art-def09de0a9cb4266802eb7df25eb94f1
institution DOAJ
issn 2590-0595
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Kidney Medicine
spelling doaj-art-def09de0a9cb4266802eb7df25eb94f12025-08-20T02:55:29ZengElsevierKidney Medicine2590-05952025-04-017410097310.1016/j.xkme.2025.100973Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to DialysisEric M. Tong, MD0Hui Zhou, PhD1Katherine Pak, MS2Cheng-Wei Huang, MD3Benjamin I. Broder, MD, PhD4John J. Sim, MD5Division of Nephrology, Kaiser Permanente Woodland Hills Medical Center. Woodland Hills, CADepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA; Departments of Health Systems Science and Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CADepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CADepartments of Health Systems Science and Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA; Department of Hospital Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CADepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA; Departments of Health Systems Science and Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA; Regional Quality and Clinical Analysis, Southern California Permanente Medical Group, Pasadena, CADepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA; Departments of Health Systems Science and Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA; Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA; Address for Correspondence: John J. Sim, MD, Division of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, 4700 Sunset Blvd, Los Angeles, CA 90027.http://www.sciencedirect.com/science/article/pii/S2590059525000093
spellingShingle Eric M. Tong, MD
Hui Zhou, PhD
Katherine Pak, MS
Cheng-Wei Huang, MD
Benjamin I. Broder, MD, PhD
John J. Sim, MD
Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
Kidney Medicine
title Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
title_full Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
title_fullStr Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
title_full_unstemmed Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
title_short Mineralocorticoid Receptor Antagonist Use Among Patients With Chronic Kidney Disease Who Transitioned to Dialysis
title_sort mineralocorticoid receptor antagonist use among patients with chronic kidney disease who transitioned to dialysis
url http://www.sciencedirect.com/science/article/pii/S2590059525000093
work_keys_str_mv AT ericmtongmd mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis
AT huizhouphd mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis
AT katherinepakms mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis
AT chengweihuangmd mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis
AT benjaminibrodermdphd mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis
AT johnjsimmd mineralocorticoidreceptorantagonistuseamongpatientswithchronickidneydiseasewhotransitionedtodialysis